Please try another search
For the nine months ended 31 December 2021, Tauriga Sciences Inc revenues increased 13% to $243K. Net loss increased from $1.6M to $4.1M. Revenues reflect Gross revenue increase from $95K to $284K. Higher net loss reflects Unrealized gain (loss) on trading securi decrease from $999K (income) to $911K (expense), General and Administrative increase from $1.3M to $2.9M (expense).
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Revenue | 0.1 | 0.14 | 0.03 | 0.07 |
Gross Profit | 0.06 | 0.06 | 0.02 | 0.04 |
Operating Income | -1.34 | -2.18 | -0.98 | -1.99 |
Net Income | -1.54 | -2.57 | -0.83 | -2.01 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Assets | 1.62 | 1.98 | 2.76 | 2.49 |
Total Liabilities | 2.36 | 2 | 1.5 | 1.22 |
Total Equity | -0.75 | -0.03 | 1.25 | 1.27 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -1.44 | -1.18 | -0.76 | -2.5 |
Cash From Investing Activities | -0 | -0 | -0 | -0.42 |
Cash From Financing Activities | 1.4 | 1.16 | 0.78 | 2.97 |
Net Change in Cash | -0.04 | -0.02 | 0.02 | 0.04 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review